Erscheint 6 Ausgaben pro Jahr
ISSN Druckformat: 1045-4403
ISSN Online: 2162-6502
Indexed in
Prostate Cancer and Parasitism of the Bone Hematopoietic Stem Cell Niche
ABSTRAKT
A subpopulation of men that appear cured of prostate cancer (PCa) develop bone metastases many years after prostatectomy. This observation indicates that PCa cells were present outside of the prostate at the time of prostatectomy and remained dormant. Several lines of evidence indicate that there are disseminated tumor cells (DTCs) in the bone marrow at the time of prostatectomy. DTCs parasitize the bone microenvironment, where they derive support and impact the microenvironment itself. These DTCs appear to be a heterogeneous population of PCa cells; however, some of them appear to have some aspects of a cancer stem cell (CSC) phenotype as they can develop into clinically detectable metastases. The concept of CSC is controversial; however, several markers of CSC have been identified for PCa, which may represent cells of either basal or luminal origin. These DTCs have now been shown to compete for the hematopoietic stem cell niche in bone, where they may be placed in a dormant state. Interaction with a variety of host factors, including cytokine and cells, may impact the metastatic development and progression, including the dormant state. For example, myeloid cells have been shown to impact both the premetastatic niche and established tumors. Understanding the concepts of how PCa successfully parasitizes the bone microenvironment is paramount toward identifying therapeutic candidates to prevent or diminish PCa bone metastases.
-
Chang L, Graham P H, Hao J, Ni J, Bucci J, Cozzi P J, Kearsley J H, Li Y, Acquisition of epithelial–mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance, Cell Death & Disease, 4, 10, 2013. Crossref
-
Nawroth R., Weckermann D., Retz M., Prostata- und Harnblasenkarzinom, Der Urologe, 53, 4, 2014. Crossref
-
Wang Ning, Docherty Freyja E, Brown Hannah K, Reeves Kimberley J, Fowles Anne CM, Ottewell Penelope D, Dear T Neil, Holen Ingunn, Croucher Peter I, Eaton Colby L, Prostate Cancer Cells Preferentially Home to Osteoblast-rich Areas in the Early Stages of Bone Metastasis: Evidence From In Vivo Models, Journal of Bone and Mineral Research, 29, 12, 2014. Crossref
-
Cook Leah M., Shay Gemma, Aruajo Arturo, Lynch Conor C., Integrating new discoveries into the “vicious cycle” paradigm of prostate to bone metastases, Cancer and Metastasis Reviews, 33, 2-3, 2014. Crossref
-
Hofbauer Lorenz C, Rachner Tilman D, Coleman Robert E, Jakob Franz, Endocrine aspects of bone metastases, The Lancet Diabetes & Endocrinology, 2, 6, 2014. Crossref
-
Gernone Angela, Bordonaro Sebastiano, Tralongo Paolo, Optimal sequence of bone target drugs in metastatic prostatic cancer, Expert Review of Anticancer Therapy, 15, 8, 2015. Crossref
-
Reagan Michaela R., Rosen Clifford J., Navigating the bone marrow niche: translational insights and cancer-driven dysfunction, Nature Reviews Rheumatology, 12, 3, 2016. Crossref
-
Morhayim Jess, van de Peppel Jeroen, Braakman Eric, Rombouts Elwin W. J. C., ter Borg Mariette N. D., Dudakovic Amel, Chiba Hideki, van der Eerden Bram C. J., Raaijmakers Marc H., van Wijnen Andre J., Cornelissen Jan J., van Leeuwen Johannes P., Osteoblasts secrete miRNA-containing extracellular vesicles that enhance expansion of human umbilical cord blood cells, Scientific Reports, 6, 1, 2016. Crossref
-
Taichman Russell S., Patel Lalit R., Bedenis Rachel, Wang Jingcheng, Weidner Savannah, Schumann Taibriana, Yumoto Kenji, Berry Janice E., Shiozawa Yusuke, Pienta Kenneth J., Tang Dean G., GAS6 Receptor Status Is Associated with Dormancy and Bone Metastatic Tumor Formation, PLoS ONE, 8, 4, 2013. Crossref
-
CIFUENTES FEDERICO F., VALENZUELA RODRIGO H., CONTRERAS HÉCTOR R., CASTELLÓN ENRIQUE A., Surgical cytoreduction of the primary tumor reduces metastatic progression in a mouse model of prostate cancer, Oncology Reports, 34, 6, 2015. Crossref
-
Vignani Francesca, Bertaglia Valentina, Buttigliero Consuelo, Tucci Marcello, Scagliotti Giorgio V., Di Maio Massimo, Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancer, Cancer Treatment Reviews, 44, 2016. Crossref
-
Jaworska Dagmara, Król Wojciech, Szliszka Ewelina, Prostate Cancer Stem Cells: Research Advances, International Journal of Molecular Sciences, 16, 11, 2015. Crossref
-
van der Horst Geertje, van der Mark Maaike, Cheung Henry, van der Pluijm Gabri, Transplantable Animal Studies and Whole-Body Optical Imaging in Prostate Carcinoma, in Prostate Cancer, 1786, 2018. Crossref
-
Tivari Samir, Lu Haiyan, Dasgupta Tanya, De Lorenzo Mariana S., Wieder Robert, Reawakening of dormant estrogen-dependent human breast cancer cells by bone marrow stroma secretory senescence, Cell Communication and Signaling, 16, 1, 2018. Crossref
-
Sampayo Rocío G., Bissell Mina J., , 144, 2019. Crossref
-
Rhoades (Sterling) Julie A., Johnson Rachelle W., Lynch Conor C., Localized osteolysis, in Principles of Bone Biology, 2020. Crossref
-
Herrmann Marietta, Jakob Franz, Bone Marrow Niches for Skeletal Progenitor Cells and their Inhabitants in Health and Disease, Current Stem Cell Research & Therapy, 14, 4, 2019. Crossref
-
Cursano M.C., Iuliani M., Casadei C., Stellato M., Tonini G., Paganelli G., Santini D., De Giorgi U., Combination radium-223 therapies in patients with bone metastases from castration-resistant prostate cancer: A review, Critical Reviews in Oncology/Hematology, 146, 2020. Crossref
-
Li Feng, Glinskii Olga V., Mooney Brian P., Rittenhouse-Olson Kate, Pienta Kenneth J., Glinsky Vladislav V., Cell surface Thomsen-Friedenreich proteome profiling of metastatic prostate cancer cells reveals potential link with cancer stem cell-like phenotype, Oncotarget, 8, 58, 2017. Crossref
-
Costanzo-Garvey Diane L., Keeley Tyler, Case Adam J., Watson Gabrielle F., Alsamraae Massar, Yu Yangsheng, Su Kaihong, Heim Cortney E., Kielian Tammy, Morrissey Colm, Frieling Jeremy S., Cook Leah M., Neutrophils are mediators of metastatic prostate cancer progression in bone, Cancer Immunology, Immunotherapy, 69, 6, 2020. Crossref
-
San Martin Rebeca, Pathak Ravi, Jain Antrix, Jung Sung Yun, Hilsenbeck Susan G., Piña-Barba María C., Sikora Andrew G., Pienta Kenneth J., Rowley David R., Tenascin-C and Integrin α9 Mediate Interactions of Prostate Cancer with the Bone Microenvironment, Cancer Research, 77, 21, 2017. Crossref